The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, has reported 7,523 new cases of Covid-19 that have been identified in South Africa in the past 24 hours.
This brings the total number of laboratory confirmed cases to 3,852,148. This increase represents a positive rate of 23.0%.
Most of the new cases today come from Gauteng (38%), followed by KwaZulu-Natal (24%). Western Cape accounted for 17%; The Eastern Cape accounted for 8%; Free State accounted for 5%; The Northwest accounted for 4%; Mpumalanga accounted for 3%; and Limpopo and Northern Cape respectively accounted for 1% of new cases today.
The country also recorded 26 deaths and of these, 8 occurred in the past 24-48 hours. The cumulative deaths from Covid-19 are 100,559 to date.
24,726,029 tests were conducted in both the public and private sectors.
There has been an increase of 148 hospital admissions in the past 24 hours.
The South African Health Products Regulatory Authority (SAHPRA) has yet to clarify the details on the side effects related to the Johnson and Johnson Covid-19 vaccine.
Researchers with the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention in the United States found that the vaccine resulted in 60 confirmed cases of thrombosis with thrombocytopenia syndrome.
This leads to rare but potentially life-threatening blood clots, the FDA said, one to two weeks after receiving the injection.
With more vaccines available, the FDA has decided to bench the J&J vaccine, to be used only when other options are unavailable.
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the institute recognizes that the Janssen Covid-19 vaccine still plays a role in the current pandemic response in the United States and the global community.
Additional reporting of Faizel Patel